Aralen ( Chloroquine) has been studied for the treatment and prevention of coronavirus disease 2019 (COVID-19). The FDA had approved an Emergency Use Authorization (EUA) on March 28, 2020 to allow distribution of Aralen for the treatment adults and adolescents who weigh at least 110 pounds (50 kg) and who are hospitalized with COVID-19, but who are unable to participate in a clinical study.
April 23, 2021 at 05:27AM
from Dr. Linex https://ift.tt/2QgIpIt
via IFTTT
0 comments:
Post a Comment